Stockreport

FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.

Tempus AI, Inc. - Class A  (TEM) 
PDF Oran Muduroglu, proven medical imaging entrepreneur, to lead U.S. launch of eyonis® LCSEstablished U.S. commercial and clinical infrastructure combined with Medicare rei [Read more]